Novel Rare SORL1 Variants in Early-Onset Dementia
- PMID: 34092641
- DOI: 10.3233/JAD-210207
Novel Rare SORL1 Variants in Early-Onset Dementia
Abstract
Background: Rare variants of SORL1 have been associated with an increased risk of early-onset or late-onset Alzheimer's disease (AD). However, a lot remains to be clarified about their significance in the pathogenesis of the disease.
Objective: To evaluate the role of SORL1 variants among Finnish patients with early-onset AD (EOAD).
Methods: The rare SORL1variants were screened in a cohort of 115 Finnish EOAD patients (mean age at onset 58.3 years, range 46-65 years) by using the whole-exome sequencing.
Results: We found one novel nonsense variant (p.Gln290*) and eight missense variants in SORL1. This is the first study reporting the SORL1 variants p.Lys80Arg, p.Ala789Val and p.Arg866Gln in EOAD patients. Furthermore, two of these three missense variants were overrepresented in EOAD patients compared to gnomAD non-neuro Finnish samples.
Conclusion: This study strengthens the earlier findings, that the rare variants in SORL1 are associated with EOAD.
Keywords: Dementia; SORL1; early onset Alzheimer’s disease; gene; human; mutation; neurodegenerative disease; single nucleotide polymorphism.
Similar articles
-
Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene.Acta Neuropathol Commun. 2017 Jun 9;5(1):43. doi: 10.1186/s40478-017-0441-9. Acta Neuropathol Commun. 2017. PMID: 28595629 Free PMC article.
-
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease.Acta Neuropathol. 2016 Aug;132(2):213-224. doi: 10.1007/s00401-016-1566-9. Epub 2016 Mar 30. Acta Neuropathol. 2016. PMID: 27026413 Free PMC article.
-
SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.J Alzheimers Dis. 2017;58(4):1121-1128. doi: 10.3233/JAD-170005. J Alzheimers Dis. 2017. PMID: 28527213
-
SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.Acta Neuropathol. 2019 Aug;138(2):173-186. doi: 10.1007/s00401-019-01991-4. Epub 2019 Mar 25. Acta Neuropathol. 2019. PMID: 30911827 Review.
-
Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.Curr Gene Ther. 2021;21(1):43-52. doi: 10.2174/1566523220666201123112822. Curr Gene Ther. 2021. PMID: 33231156 Review.
Cited by
-
Haploinsufficiency and Alzheimer's Disease: The Possible Pathogenic and Protective Genetic Factors.Int J Mol Sci. 2024 Nov 7;25(22):11959. doi: 10.3390/ijms252211959. Int J Mol Sci. 2024. PMID: 39596030 Free PMC article. Review.
-
AD-Syn-Net: systematic identification of Alzheimer's disease-associated mutation and co-mutation vulnerabilities via deep learning.Brief Bioinform. 2023 Mar 19;24(2):bbad030. doi: 10.1093/bib/bbad030. Brief Bioinform. 2023. PMID: 36752347 Free PMC article.
-
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease.Mol Neurodegener. 2022 Nov 18;17(1):74. doi: 10.1186/s13024-022-00576-2. Mol Neurodegener. 2022. PMID: 36397124 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical